Changes in Streptococcus pneumoniae serotype distribution in invasive disease and nasopharyngeal carriage after the heptavalent pneumococcal conjugate vaccine introduction in Bogotá, Colombia

Vaccine

Volumn 31, Issue 37, 2013, Pages 4033-4038

  Parra, Eliana L ^a   De La Hoz, Fernando ^b   Díaz, Paula L ^a   Sanabria, Olga ^a   Realpe, María Elena ^a   Moreno, Jaime ^a  

^a INSTITUTO NACIONAL DE SALUD   (Colombia)

^b UNIVERSIDAD NACIONAL DE COLOMBIA   (Colombia)

Author keywords

Nasopharyngeal carriage; Pneumococcal conjugate vaccine; Streptococcus pneumoniae serotypes

Indexed keywords

CEFTRIAXONE; CHLORAMPHENICOL; COTRIMOXAZOLE; ERYTHROMYCIN; PENICILLIN DERIVATIVE; PNEUMOCOCCUS VACCINE; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM IDENTIFICATION; CHILD; COLOMBIA; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; NASOPHARYNX; PNEUMOCOCCAL INFECTION; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPE; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

NASOPHARYNGEAL CARRIAGE; PNEUMOCOCCAL CONJUGATE VACCINE; STREPTOCOCCUS PNEUMONIAE SEROTYPES;

ANTI-BACTERIAL AGENTS; CARRIER STATE; COLOMBIA; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INFANT; MALE; MICROBIAL SENSITIVITY TESTS; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE;

EID: 84881556009     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2013.04.074     Document Type: Article

References (47)

1. WHO Publication Pneumococcal vaccines WHO position paper - 2012. Wkly Epidemiol Rec 2012, 87:129-144.
2. Bogaert D., De Groot R., Hermans P.W. Streptococcus pneumoniae colonization: the key to pneumococcal disease. Lancet Infect Dis 2004, 4:144-154.
3. Park I.H., Pritchard D.G., Cartee R., Brandao A., Brandileone M.C., Nahm M.H. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J Clin Microbiol 2007, 45:1225-1233.
4. Jin P., Kong F., Xiao M., Oftadeh S., Zhou F., Liu C., et al. First report of putative Streptococcus pneumoniae serotype 6D among nasopharyngeal isolates from Fijian children. J Infect Dis 2009, 200:1375-1380. 10.1086/606118.
5. Calix J.J., Nahm M.H. A new pneumococcal serotype, 11E, has a variably inactivated wcjE gene. J Infect Dis 2010, 202:29-38.
6. Calix J.J., Porambo R.J., Brady A.M., Larson T.R., Yother J., Abeygunwardana C., et al. Biochemical, genetic, and serological characterization of two capsule subtypes among Streptococcus pneumoniae serotype 20 strains: discovery of a new pneumococcal serotype. J Biol Chem 2012, 287:27885-27894.
7. Johnson H.L., Deloria-Knoll M., Levine O.S., Stoszek S.K., Freimanis Hance L., Reithinger R., Muenz L.R., O'Brien K.L. Systematic evaluation of serotypes causing invasive pneumococcal disease among children under five: the pneumococcal global serotype project. PLoS Med 2010, 7(October, 10). doi:pii: e1000348.10.1371/journal.pmed.1000348.
8. Tan T.Q. Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines. Clin Microbiol Rev 2012, 25:409-419.
9. Tocheva A.S., Jefferies J.M., Rubery H., Bennett J., Afimeke G., Garland J., et al. Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children. Vaccine 2011, 29:4400-4404.
10. Spijkerman J., van Gils E.J., Veenhoven R.H., Hak E., Yzerman E.P., van der Ende A., et al. Carriage of Streptococcus pneumoniae 3 years after start of vaccination program, the Netherlands. Emerg Infect Dis 2011, 17:584-591.
11. Huang S.S., Hinrichsen V.L., Stevenson A.E., Rifas-Shiman S.L., Kleinman K., Pelton S.I., et al. Continued impact of pneumococcal conjugate vaccine on carriage in young children. Pediatrics 2009, 124:e1-e11.
12. Flasche S., Van Hoek A.J., Sheasby E., Waight P., Andrews N., Sheppard C., et al. Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS Med 2011, 8:e1001017. 10.1371/journal.pmed.1001017.
13. Di Fabio J.L., Castañeda E., Agudelo C.I., de la Hoz F., Hortal M., Camout T., et al. Evolution of Streptococcus pneumoniae serotypes and penicillin susceptibility in Latin America, Sireva-Vigía group 1993-1999. Pediatr Infect Dis J 2001, 20:959-967.
14. Ministerio de Salud y Protección Social. Jornada de Vacunación en Las Américas 2012, 2013 [accessed February 2013]. http://www.minsalud.gov.co/Lineamientos/Documento_Marco_Jornada_de_Vacunacion_de_las_Americas_abril%202012.
15. Garcia S., Lagos R., Muñoz A., Picón T., Rosa R., Alfonso A., et al. Impact of vaccination against Haemophilus influenzae type b with and without a booster dose on meningitis in four South American countries. Vaccine 2012, 30:486-492.
16. Moreno J., Hernández E., Sanabria O., Castañeda E. Detection and serotyping of Streptococcus pneumoniae from nasopharyngeal samples by PCR-based multiplex assay. J Clin Microbiol 2005, 43:6152-6154.
17. Pai R., Gertz R.E., Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J Clin Microbiol 2006, 44:124-131.
18. Messmer T.O., Sampson J.S., Stinson A., Wong B., Carlone G.M., Facklam R.R. Comparison of four polymerase chain reaction assays for specificity in the identification of Streptococcus pneumoniae. Diagn Microbiol Infect Dis 2004, 49:249-254.
19. Carvalho Mda G., Pimienta F.C., Gertz R.E., Joshi H.H., Trujillo A.A., Keys L.E., et al. PCR-based quantitation and clonal diversity of current prevalent invasive serogroup 6 pneumococal serotype, 6C, in the United States in 1999 and 2006 to 2007. J Clin Microbiol 2009, 47:554-559.
20. CLSI Performance Standards for Antimicrobial Susceptibility Testing; Twenty-First Informational Supplement. CLSI document M100-S21 2011, Clinical Laboratory Standards Institute, Wayne, PA.
21. Solórzano-Santos F., Ortiz-Ocampo L.A., Miranda-Novales M.G., Echániz-Avilés G., Soto-Noguerón A., Guiscafré-Gallardo H. Prevalence of Streptococcus pneumoniae serotypes on nasopharyngeal colonization in children of Mexico City. Salud Publica Mex 2005, 47:276-281.
22. Laval C.B., de Andrade A.L., Pimenta F.C., de Andrade J.G., de Oliveira R.M., Silva S.A., et al. Serotypes of carriage and invasive isolates of Streptococcus pneumoniae in Brazilian children in the era of pneumococcal vaccines. Clin Microbiol Infect 2006, 12:50-55.
23. Mercado E.H., Egoavil M., Horna S.G., Torres N., Velásquez R., Castillo M.E., et al. Pneumococcal serotypes in carrier children prior to the introduction of anti-pneumococcal vaccines in Peru. Rev Peru Med Exp Salud Publica 2012, 29:53-60.
24. Lo W.T., Wang C.C., Yu C.M., Chu M.L. Rate of nasopharyngeal carriage, antimicrobial resistance and serotype of Streptococcus pneumoniae among children in northern Taiwan. J Microbiol Immunol Infect 2003, 36:175-181.
25. Ho P.L., Chiu S.S., Chan M.Y., Ang I., Chow K.H., Lau Y.L. Changes in nasopharyngeal carriage and serotype distribution of antibiotic-resistant Streptococcus pneumoniae before and after the introduction of 7-valent pneumococcal conjugate vaccine in Hong Kong. Diagn Microbiol Infect Dis 2011, 71:327-334.
26. Adetifa I.M., Antonio M., Okoromah C.A., Ebruke C., Inem V., Nsekpong D., et al. Pre-vaccination nasopharyngeal pneumococcal carriage in a Nigerian population: epidemiology and population biology. PLoS One 2012, 7:e30548. 10.1371/journal.pone.0030548.
27. Hill P.C., Akisanya A., Sankareh K., Cheung Y.B., Saaka M., Lahai G., et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian villagers. Clin Infect Dis 2006, 43:673-679.
28. Ogami M., Hotomi M., Togawa A., Yamanaka N. A comparison of conventional and molecular microbiology in detecting differences in pneumococcal colonization in healthy children and children with upper respiratory illness. Eur J Pediatr 2010, 169:1221-1225.
29. Hanage W.P., Finkelstein J.A., Huang S.S., Pelton S.I., Stevenson A.E., Kleinman K., et al. Evidence that pneumococcal serotype replacement in Massachusetts following conjugate vaccination is now complete. Epidemics 2010, 2:80-84.
30. O'Brien K.L., Millar E.V., Zell E.R., Bronsdon M., Weatherholtz R., Reid R., et al. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in acommunity-randomized trial. J Infect Dis 2007, 196:1211-1220.
31. Van Gils E.J., Veenhoven R.H., Hak E., Rodenburg G.D., Bogaert D., Ijzerman E.P., et al. Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial. JAMA 2009, 302:159-167.
32. Agudelo C.I., Moreno J., Sanabria O.M., Ovalle M.V., Di Fabio J.L., Castañeda E., et al. Streptococcus pneumoniae: serotype evolution and patterns of antimicrobial susceptibility in invasive isolates from 11 years surveillance (1994-2004) in Colombia. Biomedica 2006, 26:234-249.
33. Benavides J.A., Ovalle O.O., Salvador G.R., Gray S., Isaacman D., Rodgers G.L. Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Bogotá, Colombia. Vaccine 2012, 30:5886-5892.
34. Thoon K.C., Chong C.Y., Tee N.W. Early impact of pneumococcal conjugate vaccine on invasive pneumococcal disease in Singapore children, 2005 through 2010. Int J Infect Dis 2012, 16:e209-e215.
35. Calbo E., Díaz A., Cañadell E., Fábrega J., Uriz S., Xercavins M., et al. Spanish Pneumococcal Infection Study Network. Invasive pneumococcal disease among children in a health district of Barcelona: early impact of pneumococcal conjugate vaccine. Clin Microbiol Infect 2006, 12:867-872.
36. Whitney C.G., Pilishvili T., Farley M.M., Schaffner W., Craig A.S., Lynfield R., et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 2006, 368:1495-1502.
37. Hausdorff W.P., Weinberger D.M., Harboe Z.B., Flasche S., Scott J.A., Lipsitch M. Prediction of serotypes causing invasive pneumococcal disease in unvaccinated and vaccinated populations. Epidemiology 2011, 22:199-207.
38. Sleeman K.L., Griffiths D., Shackley F., Diggle L., Gupta S., Maiden M.C., et al. Capsular serotype-specific attack rates and duration of carriage of Streptococcus pneumoniae in a population of children. J Infect Dis 2006, 194:682-688.
39. Hausdorff W.P. The roles of pneumococcal serotypes 1 and 5 in paediatric invasive disease. Vaccine 2007, 25:2406-2412.
40. Selva L., Ciruela P., Esteva C., de Sevilla M.F., Codina G., Hernandez S., et al. Serotype 3 is a common serotype causing invasive pneumococcal disease in children less than 5 years old, as identified by real-time PCR. Eur J Clin Microbiol Infect Dis 2012, 31:1487-1495.
41. Weinberger D.M., Harboe Z.B., Flasche S., Scott J.A., Lipsitch M. Prediction of serotypes causing invasive pneumococcal disease in unvaccinated and vaccinated populations. Epidemiology 2011, 22:199-207.
42. Yildirim I., Hanage W.P., Lipsitch M., Shea K.M., Stevenson A., Finkelstein J.S.I., et al. Serotype specific invasive capacity and persistent reduction in invasive pneumococcal disease. Vaccine 2010, 29:283-288.
43. Espinosa-de los Monteros L.E., Aguilar-Ituarte F., Jiménez-Juárez R.N., Rodríguez-Suárez R.S., Gómez-Barreto D. Streptococcus pneumoniae serotype replacement in nasopharyngeal colonization in children vaccinated with PCV7 in Mexico. Salud Publica Mex 2010, 52:4-13.
44. Gonzalez B.E., Hulten K.G., Lamberth L., Kaplan S.L., Mason E.O. U.S. Pediatric Multicenter Pneumococcal Surveillance Group. Streptococcus pneumoniae serogroups 15 and 33: an increasing cause of pneumococcal infections in children in the United States after the introduction of the pneumococcal 7-valent conjugate vaccine. Pediatr Infect Dis J 2006, 25:301-305.
45. Isaacman D.J., McIntosh E.D., Reinert R.R. Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines. Int J Infect Dis 2010, 14:e197-e209.
46. Song J.H., Dagan R., Klugman K.P., Fritzell B. The relationship between pneumococcal serotypes and antibiotic resistance. Vaccine 2012, 30:2728-2737.
47. Dagan R., Givon-Lavi N., Porat N., Greenberg D. The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial. Vaccine 2012, 30:5132-5140.